On February 28, 2025, Helix Acquisition Corp II announced a business combination agreement with TheRas, Inc. (BridgeBio Oncology Therapeutics) to merge and advance their biopharmaceutical pipeline.
AI Assistant
BRIDGEBIO ONCOLOGY THERAPEUTICS INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.